iShares iBonds 2031 Term High Yield and Income ETF (BATS:IBHK – Get Free Report) saw a significant growth in short interest in the month of June. As of June 30th, there was short interest totaling 49,309 shares, a growth of 94.7% from the June 15th total of 25,321 shares. Currently, 6.2% of the company’s shares are short sold. Based on an average daily volume of 44,468 shares, the short-interest ratio is presently 1.1 days.
Institutional Investors Weigh In On iShares iBonds 2031 Term High Yield and Income ETF
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Ascentis Independent Advisors purchased a new stake in shares of iShares iBonds 2031 Term High Yield and Income ETF during the first quarter worth $65,000. Reliant Wealth Planning acquired a new position in shares of iShares iBonds 2031 Term High Yield and Income ETF during the 3rd quarter worth $201,000. Captrust Financial Advisors acquired a new stake in shares of iShares iBonds 2031 Term High Yield and Income ETF in the 2nd quarter valued at $217,000. Finally, Flow Traders U.S. LLC acquired a new position in iShares iBonds 2031 Term High Yield and Income ETF during the third quarter worth $225,000.
iShares iBonds 2031 Term High Yield and Income ETF Stock Performance
Shares of BATS:IBHK opened at $25.62 on Friday. The firm has a 50 day simple moving average of $25.65 and a 200 day simple moving average of $25.74. iShares iBonds 2031 Term High Yield and Income ETF has a 52 week low of $25.12 and a 52 week high of $26.16.
About iShares iBonds 2031 Term High Yield and Income ETF
The iShares iBonds 2031 Term High Yield and Income ETF (IBHK) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks a market-value-weighted index of USD-denominated, high yield and BBB-rated corporate bonds maturing in 2031. The fund will terminate in December 2031 IBHK was launched on May 22, 2024 and is issued by BlackRock.
Featured Stories
- Five stocks we like better than iShares iBonds 2031 Term High Yield and Income ETF
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
- Has Broadcom Become Too Expensive for Its AI Story?
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
Receive News & Ratings for iShares iBonds 2031 Term High Yield and Income ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds 2031 Term High Yield and Income ETF and related companies with MarketBeat.com's FREE daily email newsletter.
